Which has grown faster, AXGN or NVAX?

Over the past five years, NVAX grew revenue faster — AXGN at a 13.99% CAGR versus NVAX at 118.86%.

How have AXGN and NVAX total returns compared?

Over the past 10 years, AXGN delivered 15.98% and NVAX delivered -10.98% annualized total return. Past performance doesn't predict future results.

AxoGen, Inc. (AXGN) vs Novavax, Inc. (NVAX)

A side-by-side comparison of AxoGen, Inc. and Novavax, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AXGN

AxoGen, Inc.

$1.95B

$36.31HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

NVAX

Novavax, Inc.

$1.86B

$11.32HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — AXGN vs NVAX

growth of $100 · dividends reinvested · last 10y

AXGN +326.8% (+15.6%/yr)NVAX -59.7% (-8.7%/yr)AXGN compounded faster over this window

Log scale — wide-divergence pair

AXGN NVAX

AXGN vs NVAX: by the numbers

•AXGN is the larger company ($1.95B vs $1.86B market cap).
•Both run net losses; AXGN's is the smaller (-13.36% vs -59.87% net margin).
•NVAX grew revenue faster over the past five years (118.86% vs 13.99% CAGR).

Metrics side by side

Valuation

Metric	AXGN	NVAX
Forward P/E	82.06	N/A
P/S ratio	7.77	4.50
P/B ratio	7.62	N/A
FCF yield	0.13%	N/A

Profitability

Metric	AXGN	NVAX
Gross margin	74.56%	93.67%
Operating margin	-5.12%	50.14%
Net margin	-13.36%	-59.87%
ROE	-13.09%	N/A
ROIC	-4.68%	-36.37%

Growth (annualized)

Metric	AXGN	NVAX
Revenue CAGR (5Y)	13.99%	118.86%
Total return CAGR (5Y)	19.40%	-40.61%

Frequently asked

Which has grown faster, AXGN or NVAX?: Over the past five years, NVAX grew revenue faster — AXGN at a 13.99% CAGR versus NVAX at 118.86%.
How have AXGN and NVAX total returns compared?: Over the past 10 years, AXGN delivered 15.98% and NVAX delivered -10.98% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AXGN analysis Full NVAX analysis Interactive comparison tool

Dig into the metrics

AxoGen ROE Novavax ROE AxoGen operating margin Novavax operating margin AxoGen revenue growth Novavax revenue growth AxoGen free cash flow Novavax free cash flow

AxoGen & Novavax appear in these rankings

Fastest Revenue Growth Stocks Highest Operating Margin Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.